34 results
8-K
EX-99.1
THER
Theralink Technologies, Inc.
29 Jun 23
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
4:01pm
genes associated with increased risk of breast and ovarian cancer; provided oversight for tests used to detect mutations in genes associated with Lynch
8-K
THER
Theralink Technologies, Inc.
29 Jun 23
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
4:01pm
genes associated with increased risk of breast and ovarian cancer; provided oversight for tests used to detect mutations in genes associated with Lynch
8-K
EX-10.3
0eelmdd
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K/A
EX-99.1
z21es46 w9vcf1k
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
DEFM14C
yqhec
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
0ydipyf9whzh
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
t8y0s
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-2.1
o4m4zncj9tr j2iw1256
13 May 20
Entry into a Material Definitive Agreement
5:10pm
8-K/A
EX-10.2
i0o si63oojufyi
21 Feb 19
Financial Statements and Exhibits
5:14pm
8-K/A
EX-99.1
tvfyrmgrtyf 511khm4
2 Jul 18
Index to Financial Statements
4:05pm